| Revenue growth | 17.5% YoY consolidated growth. |
|---|---|
| Margins | Operating EBITDA margin at 22.3% (consolidated). |
| Demand visibility | Steady hospital occupancy at 68.7% and diagnostic volume growth. |
Growth
Hospital revenues grew 19% to INR 2,187 Cr. Diagnostics gross revenue increased 10.2% to INR 407 Cr.
Outlook
Ongoing expansion includes robotic surgical systems and new specialized institutes for Myeloma, Lymphoma, and Neurosciences.
Risks
Hospital occupancy slightly dipped to 68.7% from 69% YoY. ARPOB growth was modest at 2.6%.
Last quarter's promises, checked
Delivered
- Guided ~22-23% EBITDA margin for Diagnostics → delivered 23.2% (= BEAT)
- Guided ~15% hospital revenue growth → delivered 19% (= BEAT)
- Guided 1.5-2% annual margin expansion → delivered 180bps increase (= BEAT)
Partly delivered
- Guided 150bps margin improvement for FY27 → delivered 22.3% vs 22.8% FY26 (= PARTIAL)
Investor Presentation filed with BSE, NSE: FORTIS. Summary written with AI assistance from the document.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹774.90
- Market cap
- ₹58,502 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 55.8×Sector 53.1×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 25.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Legal & Regulatory
Northern TK Venture Pte Ltd, Fortis Healthcare's promoter, has appealed a Tokyo District Court judgment to the Tokyo High Court. The litigation concerns losses related to delayed tender offer approvals.
Fortis Healthcare Partnership
Fortis Hospotel signed definitive agreements with SLJ Society to provide healthcare services at their 400+ bed hospital. Fortis will provide a ₹567 Crore loan.
- Value
- ₹567.0 Cr
- From
- Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society)
- hospital beds
- 400.0 beds
Fortis Healthcare Legal & Regulatory
Tokyo District Court dismissed all NTK claims against Daiichi Sankyo; NTK must bear litigation costs. NTK is reviewing the judgment and evaluating appeal options.
Fortis Healthcare Earnings Call Transcript: Key Takeaways
Management conference call discussing a Delhi High Court order regarding a forensic audit. Operating plans, including capex, bed expansion, and M&A, remain unaffected and fully funded by internal accruals.
Fortis Healthcare Legal & Regulatory
The Delhi High Court has ordered a forensic audit concerning shareholding changes and control of Fortis Healthcare's erstwhile promoters. The company faces no liability or penalty.
Fortis Healthcare Other Announcement
Fortis Healthcare Limited received a voluntary ESG rating for FY 2025-26 from Crisil ESG Ratings & Analytics Ltd, with a rating category of 'Strong'.